大蒜 / 大蒜精 Garlic

INT-garlic-001 3 個適應症被研究
B 1 D 2

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:cautious
FDA has concluded that the statement is not an 'authoritative statement' under section 403(r)(3)(C) of the act because it is not based on a deliberative review of the scientific evidence.
來源 ↗
L4b · EU EFSA
立場:against
L4c · UK NHS
立場:not_addressed
Milder but flavourful foods like garlic and onion can also bring it on.
來源 ↗
L4d · TW TFDA / 衛福部
立場:supportive
大蒜仍屬食品,並無治療疾病的效果(食藥署闢謠專區,2020)。大蒜精與抗凝血劑(如 Warfarin)併用時可加強抗凝血藥物作用,同時也增強其副作用;病人在服藥期間應避免過量攝取大蒜而影響凝血功能(食藥好文網,食補混搭抗凝血劑恐致大出血)。
來源 ↗
L4e · WHO
立場:supportive
As an adjuvant to dietetic management in the treatment of hyperlipidaemia, and in the prevention of atherosclerotic (age-dependent) vascular changes. The drug may be useful in the treatment of mild hypertension.
來源 ↗

市場與行銷 (L10)

L10a · TW Market Channels
BHK's大蒜精軟膠囊60粒NT$390
L10b · TW Legal Identity (TFDA)
食品不得為醫療效能之標示、宣傳或廣告(食安法 §28)
L10c · TW Community (PTT/Dcard/Mobile01)
大蒜精剛流行時,許多人吃過很多盒,但幾乎沒什麼用